Area of research
Surgery · Oncology
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, COVID-19 and healthcare impacts, Renal cell carcinoma treatment, and COVID-19 Clinical Research Studies.
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study
Telemedicine Trends in Ambulatory Surgical Oncology: A Five-Year Analysis of Visit Volume and Utilization at a High-Volume Academic Center
Treatment‐Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the <scp>UNITE</scp> Study
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Remote Oncology Care: Review of Current Technology and Future Directions
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study